Downloaded from EMILIN (Elastin Microfibril Interfase Located Protein) is an elastic fiber associated glycoprotein consisting of a self-interacting globular C1q (gC1q) domain at the C-terminus, a short collagenous stalk, an extended region of potential coiled-coil structure, and a Nterminal cysteine-rich domain (EMI domain). Using the gC1q domain as a bait in the yeast two-hybrid system, we have isolated a cDNA encoding a novel protein. Determination of the entire primary structure demonstrated that this EMILIN-binding-polypeptide is highly homologous to EMILIN. The domain organization is superimposable, one important difference being a proline-rich (41%) segment of 56 residues between the potential coiledcoil region and the collagenous domain absent in EMILIN. The entire gene (localized on chromosome 18p11.3) was isolated from a BAC clone and it is structurally almost identical to that of EMILIN (8 exons, 7 introns with identical phases at the exon/intron boundaries), but much larger (about 40 kb vs 8 kb) than that of EMILIN. Given these findings we propose to name the novel protein EMILIN-2 and the prototype member of this family EMILIN-1 (formerely EMILIN). The mRNA expression of EMILIN-2 is more restricted compared to that of EMILIN-1: highest levels are present in fetal heart and adult lung, whereas, differently from EMILIN-1, adult aorta, small intestine, and appendix show very low expression, and adult uterus and fetal kidney are negative. Finally, the EMILIN-2 protein is secreted extracellularly by in vitro grown cells and, in accord with the partial co-expression in fetal and adult tissues, the two proteins shown extensive but not absolute immunocolocalization in vitro. The elasticity of many tissues such as lung, dermis, and large blood vessels depends on the presence of a high content of elastic fibers in the ECM 1 . These structures are composed of two distinct morphological elements: a more abundant amorphus core of which elastin, responsable for the elastic properties, is the major constituent; and microfibrillar structures of about 10-12 nm diameter, which are located around the periphery of the amorphus component and consist primarily of fibrillin-1 and/or -2 (1, 2). While the amorphous elastic core is apparently poorly organized, fibrillin-containing microfibrils are highly organized structures. Several components that contribute to the elastic fiber organization have been identified and cloned, including Microfibril-Associated Protein 1 to 4 (3-6), LatentTransforming growth factor β-Binding Protein 1 to 4 (7-10), fibulins 1 and 2 (11,12), Microfibril-Associated Glycoprotein-2 (13) and EMILIN (14). The latter is synthesized in vitro and it is deposited extracellularly as a fine network (15, 16); it is broadly expressed in connective tissues, and it is particularly abundant in blood vessels, skin, heart, lung, kidney and cornea (17) (18) (19) . EMILIN is found at the interface between amorphous elastin and microfibrils (14) and it might regulate the formation of the elastic fiber given the finding that elastin deposition in vitro is perturbed by the addition of anti-EMILIN antibodies (14).
The elasticity of many tissues such as lung, dermis, and large blood vessels depends on the presence of a high content of elastic fibers in the ECM 1 . These structures are composed of two distinct morphological elements: a more abundant amorphus core of which elastin, responsable for the elastic properties, is the major constituent; and microfibrillar structures of about 10-12 nm diameter, which are located around the periphery of the amorphus component and consist primarily of fibrillin-1 and/or -2 (1, 2) . While the amorphous elastic core is apparently poorly organized, fibrillin-containing microfibrils are highly organized structures. Several components that contribute to the elastic fiber organization have been identified and cloned, including Microfibril-Associated Protein 1 to 4 (3-6), LatentTransforming growth factor β-Binding Protein 1 to 4 (7-10), fibulins 1 and 2 (11, 12) , Microfibril-Associated Glycoprotein-2 (13) and EMILIN (14) . The latter is synthesized in vitro and it is deposited extracellularly as a fine network (15, 16) ; it is broadly expressed in connective tissues, and it is particularly abundant in blood vessels, skin, heart, lung, kidney and cornea (17) (18) (19) . EMILIN is found at the interface between amorphous elastin and microfibrils (14) and it might regulate the formation of the elastic fiber given the finding that elastin deposition in vitro is perturbed by the addition of anti-EMILIN antibodies (14) .
EMILIN differs from all other elastin-associated proteins and has a unique multimodular organization (20) : it includes a C1q-like globular domain at the C-terminus, endowed with cell-adhesion promoting functions, a short uninterrupted collagenous stalk, a long segment of about 650 residues with a high potential for forming coiled-coil α-helices, and a new cysteine-rich domain (EMI domain) at the N-terminus (21) . The presence of a gC1q domain and the recent identification that gC1q is structurally homologous to the tumor necrosis factor family of growth factors (22) allowed the inclusion of EMILIN in the C1q/TNF superfamily of proteins (21) . The gC1q-like domain is shared with several other ECM constituents including type VIII and type X collagens in which it represents the equivalent of the Cpropeptide of fibrillar collagens (23) (24) (25) . Given the tissue distribution of EMILIN, its proadhesive functions, and the characteristics of its domains, it is likely that EMILIN plays a fundamental role in the process of elastogenesis and might associate with other ECM constituents. However, their identification is difficult due to the low solubility of the tissue form (15) and by the very large size of recombinant EMILIN (26) that makes it poorly suitable for protein-protein interaction studies. To bypass these problems we have decided to isolate potential interactors of EMILIN by the yeast two-hybrid system that allows the measurement of specific protein-protein interactions in vivo; a vector encompassing the Cterminal gC1q-like domain, that has previously been shown to interact with itself to form homotrimers (26) , was constructed. In the present study this vector was used as a bait to screen a human kidney cDNA library and allowed the identification of a novel protein that interacts with EMILIN via their gC1q domains. This gene product, of which preliminary accounts were reported recently (21, 27 ) is homologous to EMILIN, it is encoded by a distinct gene and differs in part from EMILIN in the tissue specific expression pattern. Its mRNA was detected in a variety of human organs, including fetal heart, lung placenta, spinal cord. We propose to classify the EMILINs as a new family of extracellular proteins and to name its members as EMILIN-1 (formerly EMILIN) and EMILIN-2 (this study).
Materials and Methods
Yeast Two-hybrid Library Screening -The S. cerevisiae strains EGY48 [p8op-lacZ] (MATα, his3, trp1, ura3, LexAop(x6)-LEU2) carrying the reporter plasmid p8pop-LacZ and YM4271 (MATa, ura3-52, his3-200, lys2-801, ade2-101, ade5, trp1-901, leu2-3, 112, tyr1-501, gal4-d512, gal80-D538, ade5-hisG) were used for all assays. Yeast cultures were grown at 30 °C in either YPD (1% yeast extract, 2% peptone , and 2% glucose ) or SD minimal medium (0.5% yeast nitrogen base without amino acids , 2% glucose , and 1% desired amino acid dropout solution). Growth and manipulation of yeast strains was carried out using the procedures described in the Matchmaker Two-Hybrid system user manual (Clontech Laboratories Inc., Palo Alto, CA, USA). For our studies, a bait was constructed by cloning in the LexA plasmid the C-terminal domain of EMILIN-1 (gC1q-1), generated by PCR amplifications using 1 ng of pCEpu-EMILIN template (26) Library screening -The entire coding sequence of the cDNA isolated in the yeast twohybrid system was determined by cDNA library screening. The insert from one selected yeast two-hybrid system clone (about 1000 bp) was labeled by the random primer method with the multiprime kit (Amersham Pharmacia Biotech) and utilized to screen, by the plaque hybridization method, about 300,000 clones of a human kidney cDNA library in the λgt10 vector (Clontech). Successive rounds of screening of a human aorta cDNA library in the λgt10 vector with the most 5'-end clones resulted in the isolation of overlapping clones comprising the full length cDNA of EMILIN-2. The sequences were performed using the Big Dye terminator cycle sequencing kit and a model 310 DNA sequencing system (Perkin Elmer-Applied Biosystem). To correct for possible TAQ polymerase errors all sequences were determined from both strands and were repeated on clones obtained from independent PCR products. All human cDNA sequences were confirmed by sequencing the EMILIN-2 gene (see below).
Isolation and Characterization of a Human Genomic DNA Clone -A human genomic BAC library was screened for specific clones at Genome System using a cDNA insert corresponding to the 5'-end of the EMILIN-2 (see below) cDNA. Two positive clones were identified and one was further characterized. It was authenticated by successful PCR reamplification of insert fragments with primers pairs derived from the EMILIN-2 cDNA sequences and it was partially characterized by restriction enzyme mapping and Southern blot. Appropriate restriction fragments were gel purified and subcloned in the pGEM 7z+ vector and then sequenced.
Dot Blot Analysis -RNA expression analysis was performed using a human multiple tissues blot from Clontech. A 32 P-labeled probe was synthesized using as template the EBP-1 clone and the multiprime labelling kit (Amersham Pharmacia Biotech). Hybridization was performed at 65°C in Rapid-hyb buffer. After film exposure the blot was stripped and hybridised with a 32 P-labeled EMILIN-1 probe. All the other procedures were performed using standard techniques.
Production of Recombinant Prokaryotic gC1q of Human EMILIN-2 (gC1q-2) and
Preparation of Monoclonal Antibodies -The sequence corresponding to the C-terminal domain of EMILIN-2 (gC1q-2) was amplified from the yeast two-hybrid system template (see above) with the following primers: sense 5'-GGGGATCCGGGCGG GGTCTGCCGCG-3'; antisense 5'-GGGGTACCTTAGAGGTGGGAAAGGAAAGGAT, where the underlined nucleotides correspond to appended BamHI (sense) and KpnI (antisense) restriction enzyme recognition sites plus two additional protective nucleotides.
The amplified gC1q-2 fragment was then ligated in frame in the 6His-tagged pQE-30 expression vector (Qiagen GmbH) and transformed in M15 cells. Positive clones were isolated and the cloned fragment was sequenced in both directions to check for errors generated by PCR. Five hundred ml of liquid culture grown at 0.6 O.D. A600 nm was induced with 2 mM IPTG for 3 hours at 37 °C. The culture was then centrifuged at 4000 xg for 20 min and the cell pellet was resuspended in sonication buffer (50 mM Na-phosphate, pH 8.0, 0.3 M NaCl) at 5 volumes per gram of wet weight. The samples were frozen in a dry ice/ethanol bath, thawn in cold water and sonicated on ice (1 min bursts/1 min cooling/2-300 watts) and cell breakage was monitored by measuring the release of nucleic acids at A260 nm. The cell lysate was centrifuged at 10,000 xg for 20 min, the supernatant was collected and purification of the 6 His-tagged recombinant fragment was performed by affinity chromatography on Ni-NTA resin (Qiagen GmbH) under native conditions. The recombinant protein was eluted from the affinity column in sonication buffer, pH 6.0 containing 10% glycerol and 0.2 M imidazole.
BALB/c mice were immunized with the recombinant gC1q-2 fragment and hybridomas that reacted with the antigen in ELISA assay were selected and subcloned twice before using. homology to the C-terminal end of EMILIN, including part of the collagenic region and the entire gC1q domain. The stop codon is followed by a quite long 3'-untranslated region. To obtain the full-length ORF, the cDNA was extended by screening a human aorta library in λgt10. Five partly overlapping cDNA clones were sequentially isolated using initially the EBP-1 fragment as the probe and then probes derived from subclones at the 5'-end of each successively isolated clone (Fig. 1, bottom The EMI domain at the N-terminus is much more conserved between the two proteins in comparison to the other EMI domain-containing gene products (Fig.3A) . The short collagenic (Fig.1, top) , suggest that also EMILIN-2 might form extended homo-associations as determined to be the case for EMILIN-1 ( 26) . Finally, one stricking difference between the two members was the finding that in EMILIN-2 the collagenic region is preceded by a sequence, absent in EMILIN-1, characterized by an unusually high proline content (41%). This novel proline-rich 55 residues-long sequence, in which the proline content exceeds 41% (compared with a 8-12% of proline content in the EMI and gC1q domains and a 2-4% in the coiled-coil regions), might be implicated in additional protein-protein interactions. (31) . The C1q-like domain is splitted in exons 7 and 8, the latter containing also the 3'-untranslated sequence; the collagenic region is encoded by exon 5 and part of 6, the latter encoding also the EMILIN-2 specific prolin-rich region. Finally, characteristic is the presence in both genes of a very uncommon large exon of about 1900 bp, in which the coiled-coil regions potentially involved in interchain interaction are clustered.
RESULTS

Identification of a binding partner for EMILIN-1 in the yeast two-hybrid assay -
Chromosomal Localization and Analysis of the EMILIN-2
The present amino acid sequence of EMILIN-1 and EMILIN-2 and the strong similarities of exon organization indicates that they are the products of closely related but distinc genes likely to be derived from a common ancestor. While this study was under way, a GenBank search using sequences originated from the BAC clone retrieved a cluster of partially characterized human genomic clones localized on chromosome 18p11.3 between the markers D18S476 and D18S481. One of the clones, corresponding to GeneBank entry AC015958, allowed the complete characterization of the 3 end of the gene, from exon 5 to the 3-untranslated region. A partial overlap exists between the very end of the EMILIN-2 gene and GenBank entry AL117592, corresponding to a cDNA of about 2100 bp. Moreover, a predicted gene (KIAA0249) with a transcript of about 6000 bp lays very close to the 3 of the EMILIN-2 gene on the opposite strand.
EMILIN-1 and EMILIN-2 are Differentially Expressed in a Variety of TissuesDistribution of EMILIN-1 and EMILIN-2 mRNAs in various adult and fetal human tissues
was studied by RNA blot hybridization on a multiple tissue blot containing 50 different tissues and developmental stages. Many tissues express EMILIN-1 mRNA in different amounts, with the highest levels in the adult small intestine, aorta, lung, uterus, and appendix and in the fetal spleen, kidney, lung, and heart; intermediate expression was detected in adult liver, ovary, colon, stomach, lymph node and spleen; adult heart, bladder, prostate, adrenal gland, mammary gland, placenta, and kidney showed low expression whereas a series of other adult tissues, including skeletal muscle and different regions of adult brain did not express EMILIN-1 mRNA at all. (Fig. 6) . The mRNA expression for EMILIN-2 resulted much more restricted, with a relative high expression in fetal heart and adult lung, intermediate levels in peripheral leukocytes, placenta, and spinal cord and low expression in fetal brain, spleen, thymus, and lung and in adult heart, aorta, testis, bone marrow, small intestine, thymus, lymph node, and appendix. While RNA spotted amounts are accurately normalized allowing a semi-quantitatve comparative analysis among the tissue mRNAs hybridised with the same probe, a direct quantitative comparison between EMILIN-1 and EMILN-2 mRNA expression is not feasible due to possible differences in hybridization efficiency between the two probes. Nevertheless, the conclusion can be reached that: i) EMILIN-1 is more widely distributed in both fetal and adult tissues; ii) EMILIN-1 is expressed at higher levels in fetal heart and fetal lung compared to adult tissues (or any other tissue); iii) EMILIN-2 is much more expressed in fetal than in adult heart; iv) conversely, adult lung shows the highest expression for EMILIN-2 as compared to fetal lung and all the other tissues; v) finally, in uterus only EMILIN-1 is expressed.
Codistribution of EMILIN-1 and EMILIN-2 in Vitro -Confocal microscopy analysis
was performed on several tumor cell lines and in a number of them a positive expression of EMILIN-2 was detected. As shown in Fig. 7 for the leiomyosarcoma cell line SK-LMS-1, EMILIN-2 specific immunofluorescence was extracellular with a diffuse meshwork pattern.
In co-labelling experiments it partially colocalized with EMILIN-1, although in some areas a predominant deposition of EMILIN-2 or EMILIN-1 could also be detected.
DISCUSSION
Candidate interactors for human EMILIN-1 were investigated by the yeast two-hybrid system. One ligand, EMILIN-2, that is secreted extracellularly and it is deposited in vitro in the ECM with a meshwork pattern, was identified using as a bait the gC1q-1 domain of EMILIN-1, and its cDNA and gene and a preliminary mRNA tissue distribution pattern are reported. The structural characteristics and the predicted domain organization of EMILIN-2 replicate closely those recently established for EMILIN-1 (20) . As a result, the structural/functional criteria defining the EMILIN members are beginning to emerge; accordingly, they are expected to be constituted of four structurally distinct regions preceded by a signal peptide. In fact, both EMILIN-1 (20) and EMILIN-2 display the newly identified EMI domain at their N-terminus. This domain is consistently found at the N-terminus downstream of the signal peptide in all EMI domain containing proteins, except for multimerin that also has a pro-peptide upstream of the EMI domain that is cleaved before secretion of the mature protein (33) . Using both qualitative and quantitative yeast two-hybrid system, the EMI-1 domain was recently found to interact with the gC1q-1 domain and even more strongly with the gC1q-2 domain (21) . This finding suggests that, in addition to the gC1q-1/gC1q-2 interaction that was instrumental in isolating the first EMILIN-2 clone from the library, the heterotypic EMI-1/gC1q-2 interaction detected in vivo in the two-hybrid system might be related to the macroassembly and tissue organization of EMILINs. The EMI-2 domain is followed by an extended discontinuous sequence with the potential of forming amphipathic coiled-coil α-helices. Although the sequence homology between the EMILINs is negligible in this domain as is the relative position of the heptad repeats, the overall propensity to form coiled-coil structures (34, 35) is similarly high in both molecules (20, 27) . EMILIN-2 is slightly larger than EMILIN-1 and harbors, right upstream of the collagenous domain, a unique proline-rich motif of 53 residues. The proline-rich region is also of potential interest for EMILIN-2 interactions and assembly: for instance and by analogy to proteins such as dystrophin, which has an overall extended conformation interrupted by proline-rich sequences representing sites of protein-protein interaction (36) or may allow bending of the protein, the proline-rich region of EMILIN-2 could provide some flexibility that is not present in EMILIN-1. Among the elastic/microfibril associated glycoproteins fibrillin-1 has one proline-rich region of equivalent length. However, differently from the proline-rich region of fibrillin-1 that is largely hydrophobic (30%) and thus unlikely to form a surface loop (37, 38) , in EMILIN-2 this region is highly hydrophylic and potentially exposed to the solvent and thus available for interactions with other ligands.
While displaying four interruptions of the Gly-X-Y triplets not detected in EMILIN-1 (20) , the collagenous domain of EMILIN-2 could still form a trimeric collagen-like region, as shown for instance in type IV collagen (39) . This sequence could participate in trimerization providing additional binding strength to the trimers. At variance from the rigid stalk that the collagenous domain would form in EMILIN-1, these imperfections could confer to the collagenous domain of EMILIN-2 more flexibility or bending capability.
Considering that upstream of this domain there is the hydrophylic proline-rich domain, a flexible rod could confer a higher probability of protein-protein interaction with potential ligands.
The close identity between the EMILIN-1 and EMILIN-2 cDNAs is further emphasised by their gene organization that is almost identical. The exon size pattern and location of introns in the coding sequence are very well conserved between the two genes and the two genes have probably evolved from a common ancestor. However, the intron sequences have diverged since the intron sizes in EMILIN-2 are much larger and the overall gene size is around 40 kb, five times larger than the EMILIN-1 gene (20) . The divergent evolution of the two genes probably reflects random loss from and/or uptake of intervening sequences into the non-coding regions of the genes after they duplicated. Interestingly, the EMILIN-2 gene is located on chromosome 18p11.3, centromerically positioned but close to the LAMA1 gene coding for the laminin α1 chain (GenBank). The precise chromosomal mapping of EMILIN-2 is not possible yet since that chromosomal region is still ill defined, but the EMILIN-2
The gC1q domains of both EMILINs have a high sequence homology including a unique stretch of 10 residues absent in all other members of the C1q/TNF superfamily identified so far (20) . The gC1q-1 domain has been shown experimentally to promote homo-trimerization of EMILIN-1 (26) ; similarly, gC1q domains of other members of the superfamily can form homo-or hetero-trimers (22, (40) (41) (42) (43) (44) (45) . Thus, it is very likely that also gC1q-2 will form trimers. The following question then arises: given the finding that the gC1q-1 bait interacted with a gC1q-2 cDNA clone of the library, is there the possibility that EMILIN-1 and EMILIN-2 can form heterotrimeric assemblies or are they compatible only with the formation of homotrimers (Fig. 8) (46) . These polymers are apparently due to intermolecular S-S bonds since both EMILIN-1 and multimerin migrate as a trimeric protomer of about 500 kDa under reducing conditions in SDS gels. EMILIN-2 also has a number of cysteines that might potentially be involved in intermolecular S-S bonds.
Recombinant EMILIN-1 promoted cell adhesion of a number of hematopoietic and nonhematopoietic cell lines (27) . In addition, a pro-adhesive function was also associated with the isolated recombinant and native gC1q-1 domain (20) suggesting that at least part of the cell-binding activity could reside in this domain. Among the numerous members of the C1q/TNF superfamily, a cell adhesive function had been reported previously for the gC1q domain of the complement C1q as well (47) . It will be a matter of further studies to investigate whether EMILIN-2 and/or its gC1q-2 domain are endowed with a similar proadhesive function.
The data on tissue and developmental expression of EMILIN-2, while still very preliminary, allow some considerations to be drawn. The prominent expression in the fetal heart and the drastic reduction in the adult heart suggest that EMILIN-2 might be involved in or promote the development of heart chambers. On the contrary, the stricking reverse pattern observed in the lung, i.e. low expression in the fetus and high expression in the adult, indicates a potential role of EMILIN-2 in the physiology of respiration. More in depth studies and a comparative analysis of EMILINs expression in the developing mouse are necessary and should help elucidate the role played by these molecules. Finally, although formal ultrastructural proof that also EMILIN-2 is located at the elastin-microfibril interface is still lacking, the finding that the tissue distribution of EMILIN-1 and EMILIN-2 is only partly overlapping supports the notion that EMILINs contribute to the compositional and maybe functional heterogeneity of ECM structures. The two blots were exposed for the same length of time. 
